All-Trans Retinoic Acid for the Treatment of Hemophagocytic Lymphohistiocytosis
All-Trans Retinoic Acid for the Treatment of Hemophagocytic Lymphohistiocytosis
Not yet recruiting · NCT07626398 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| All-Trans Retinoic Acid for the Treatment of Hemophagocytic Lymphohistiocytosis | Hemic and Lymphatic Diseases, Lymphohistiocytosis, Hemophagocytic, histiocytosis, lymphatic system disorder, non-Langerhans cell histiocytosis | Not yet recruiting | Phase 2 / Phase 3 | 2026-06-04 | NCT07626398 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Anzhen Hospital | 149 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||